Mannose Ameliorates Radiation-Induced Intestinal Injury in Mice via Preventing Mitochondrial Dysfunction
Antioxidants & Redox Signaling · 2026
DOI: 10.1177/15230864261476850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2026. Verfasst von Yanqing Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Postgraduate Training Base of Jinzhou Medical University (The Characteristic Medical Center of PLA Rocket Force), Beijing, China. Hauptthemen laut MEDLINE: Mitochondria, Mannose, Intestines, Radiation-Protective Agents. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Aims
Radiation-induced intestinal injury (RIII) severely compromises the quality of life in patients undergoing abdominal/pelvic radiotherapy and may necessitate treatment discontinuation. To date, there is no approved agent for the prevention or treatment of RIII. This study aims to clarify the protective effects of mannose on RIII and elucidate its mechanisms of action, in order to identify new safe and effective therapeutic agents and potential therapeutic targets for the prevention and treatment of RIII.
Results
Here, we report that intraperitoneal administration of mannose, a natural bioactive monosaccharide, at 24, 12, and 2 h prior to lethal irradiation increased the survival rate of mice from 0% to 50%. Specifically, mannose pretreatment significantly blocked crypt cell apoptosis, preserved epithelial barrier integrity, attenuated intestinal inflammation, and enhanced crypt regeneration. Additionally, mannose treatment enhanced the survival of intestinal stem cells both in vitro and in vivo following radiation exposure. We further confirmed that mannose maintains mitochondrial homeostasis and alleviates cellular oxidative stress. Moreover, mannose facilitated the repair of DNA double-strand breaks, thereby inhibiting aberrant mitosis after radiation exposure. Additionally, preliminary evidence indicates that mannose does not affect the radiosensitivity of colorectal tumor cells or azoxymethane/dextran sodium sulfate-induced colorectal tumors in mice. Conclusion and Innovation: Given its low toxicity and wide availability, our findings suggest that mannose represents a promising protective strategy for RIII. Antioxid. Redox Signal. 45, 840–856.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Postgraduate Training Base of Jinzhou Medical University (The Characteristic Medical Center of PLA Rocket Force), Beijing, China.
- Department of Nuclear Radiation Injury and Monitoring, The Characteristic Medical Center of PLA Rocket Force, Beijing, China.
- Department of General Practice, The Characteristic Medical Center of PLA Rocket Force, Beijing, China.
- Research Department, The Characteristic Medical Center of PLA Rocket Force, Beijing, China.
- School of Pharmaceutical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
ORCID-Profile: Fengsheng Li
Zitieren
APA
Liu, Y., Peng, R., Zhang, Y., Dai, J., Dong, S., Yu, H., Wang, S., Chen, Z., Jiang, Q., Li, W., Yue, Y., Wang, J., Xu, J., Li, Z., & Li, F. (2026). Mannose Ameliorates Radiation-Induced Intestinal Injury in Mice via Preventing Mitochondrial Dysfunction. Antioxidants & Redox Signaling. https://doi.org/10.1177/15230864261476850
Vancouver
Liu Y, Peng R, Zhang Y, Dai J, Dong S, Yu H, et al. Mannose Ameliorates Radiation-Induced Intestinal Injury in Mice via Preventing Mitochondrial Dysfunction. Antioxidants & Redox Signaling. 2026. doi:10.1177/15230864261476850
BibTeX
@article{Liu2026,
author = {Liu, Yanqing and Peng, Renjun and Zhang, Yiying and Dai, Jing and Dong, Suhe and Yu, Huijie and Wang, Sinian and Chen, Zhongmin and Jiang, Qisheng and Li, Wei and Yue, Yining and Wang, Jianan and Xu, Jie and Li, Zhongtang and Li, Fengsheng},
title = {Mannose Ameliorates Radiation-Induced Intestinal Injury in Mice via Preventing Mitochondrial Dysfunction},
journal = {Antioxidants & Redox Signaling},
year = {2026},
doi = {10.1177/15230864261476850}
}
EUVIMED